RIFAXIMIN INDUCED HYPONATREMIA: A CASE REPORT
DOI:
https://doi.org/10.22159/ajpcr.2016.v9s3.14452Abstract
ABSTRACT
Rifaximin is one of the common drugs used in clinical practice in the management of traveler's diarrhea, irritable bowel syndrome (IBS), and hepatic
encephalopathy. Hyponatremia is one of the rare side effects of this drug. We hereby present the case of a middle-aged woman who was a known case
of IBS: Diarrhea predominant who developed symptoms of hyponatremia after a short duration of rifaximin treatment, no other cause of hyponatremia
was found on evaluation, so we suspect this as a rare side effect of rifaximin therapy.
Keywords: Rifaximin, Hyponatremia, Irritable bowel syndrome.
Downloads
References
DuPont H. Therapy for and prevention of traveler’s diarrhea. Clin
Infect Dis 2007;45(Suppl 1):S78-84.
Jolley J. High-dose rifaximin treatment alleviates global symptoms of
irritable bowel syndrome. Clin Exp Gastroenterol 2011;4:43-8.
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB,
et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med
;362:1071-81.
Pimentel M, Park S, Mirocha J, Kane SV, Kong Y. The effect of
a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the
irritable bowel syndrome: A randomized trial. Ann Intern Med
;145(8):557-63.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
